Global AI-based Drug Discovery Market Report 2021: Current Market Landscape and Future Potential of the Players Engaged in Offering AI-Based Services, Platforms and Tools - Forecast to 2030

News provided by

Feb 19, 2021, 11:45 ET

DUBLIN, Feb. 19, 2021 /PRNewswire/ -- The "AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The "AI-based Drug Discovery Market: Focus on Machine Learning and Deep Learning, 2020-2030" report features an extensive study of the current market landscape and future potential of the players engaged in offering AI-based services, platforms and tools for the discovery of novel drug candidates. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

The drug discovery process, which includes the identification of a relevant biological target and a corresponding pharmacological lead, is crucial to the clinical success of a drug candidate.

Considering the growing complexity of modern pharmacology, the discovery of viable therapeutic candidates is very demanding, both in terms of capital investment and time. In fact, according to a study conducted by Tufts Center for the Study of Drug Development, it was estimated that a prescription drug requires around 10 years and over USD 2.5 billion in capital investment, while traversing from the bench to the market. Around one-third of the aforementioned expenditure is incurred during the drug discovery phase alone.

Moreover, it is well-known that only a small proportion of pharmacological leads identified during the discovery stages are actually translated into viable product candidates for clinical studies. Currently, experts believe that close to 90% of the product candidates fail to make it past the clinical stage of development. This high attrition rate has long been attributed to the legacy drug discovery process, which is more of a trial-and-error paradigm.

In attempts to address the concerns associated with rising capital requirements in drug discovery, and prevent late stage failure of drug development programs, stakeholders in the pharmaceutical industry are currently exploring the implementation of Artificial Intelligence (AI) based tools in order to better inform drug development operations using available chemical and biological data.

A detailed review of the current market landscape of companies that claim to offer AI-based services, platforms and tools for drug discovery. It includes information on year of establishment, company size (in terms of number of employees), location of headquarters, number of AI-based platforms/tools available, type of AI technology used, drug discovery steps for which the company has expertise involving the use of AI (target identification/validation, lead identification/optimization and ADMET studies), type of drug molecule handled (small molecules, biologics and both), drug development initiatives undertaken by the firm and target therapeutic area.

One of the key objectives of this report was to estimate the existing market size and the future growth potential within the AI-based drug discovery market. We have developed informed estimates on the financial evolution of the market, over the period 2020-2030.

Key Questions Answered

Who are the leading players engaged in the AI-based drug discovery market?
Which key AI technologies are presently being most commonly adopted by drug discovery focused companies?
What is the likely valuation/net worth of companies engaged in this domain?
What is the likely cost saving potential associated with the use of AI in the drug discovery process?
Which partnership models are most commonly adopted by stakeholders engaged in this industry?
What is the overall trend of funding and investments within this domain?
How is the current and future opportunity likely to be distributed across key market segments?

Companies Mentioned

3BIGS
3W Partners
6 Dimensions Capital
8VC
99andBeyond
A2A Pharmaceuticals
Abalone Bio
AbbVie
AbCellera
Abstract Ventures
Accelerate Long Island
Accenture
Accutar Biotech
Acellera
Acequia Capital
AcuraStem
Adagene
ADC Therapeutics
ADEL
Advantage Capital
AdynXX
Agent Capital
AGORANO
AI Therapeutics
Ai-biopharma
Aigenpulse
Air Street Capital
Ajou University
Akashi Therapeutics
Albany Molecular Research
A-Level Capital
Alexandria Real Estate Equities
Alibaba Cloud
Allergan
Alliance for Clinical Trials in Oncology
Alloy Therapeutics
Almac Diagnostic Services
Almirall
Alphanosos
ALS Association
ALS Investment Fund
Altos Ventures
Amadeus Capital Partners
Amadeus Capital Partners
Amazon Web Services
Amazon Web Services (AWS)
AME Cloud Ventures
American Society of Clinical Oncology
Amgen
Amgen Ventures
Amidi Group
Amplify Partners
Amplitude
Anagenesis Biotechnologies
Andreessen Horowitz
Angel CoFund
Anima Biotech
Ansa Biotechnologies
Antiverse
ApexQubit
Aqemia
Arbutus Biopharma
ARCH Venture Partners
ArcTern Ventures
Arctoris
Ardigen
Arpeggio Biosciences
Artis Ventures
Arzeda
Asset Management Ventures
Astellas Pharma
Astia Angels
AstraZeneca
AstraZeneca's Centre for Genomics Research
ATAI Life Sciences
Atinum Investment
Atlantic Labs
Atlas Venture
Atomico
Atomwise
Atrius Health
AUM Biosciences
Auransa
Aurinvest
Auvergne-Rhone-Alpes regional council
AVIC Trust
AxoSim
B Capital Group
BABEL Ventures
Baidu Ventures
Baillie Gifford
Balderton Capital
Bangarang Group
Battelle Center for Science, Engineering, and Public Policy, Ohio State University
Bavarian Nordic
Bayer
Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC)
Beiersdorf
Benevolent AI
BERG
Better Ventures
Bezos Expeditions
Big Data Institute
BigHat Biosciences
Bill & Melinda Gates Foundation
BioAge Labs
Bioeconomy Capital
BioFocus DPI
BioInvent International
Biomea Healthcare
BioMotiv
Bionano Genomics
BioNTech
Biorelate
Bios Partners
BioSymetrics
biotx.ai
BioVentures Investors
Bioverge
Biovista
BioXcel Therapeutics
BlackRock
Block.one
Bloomberg Beta
Blue Bear Ventures
bluebird bio
Boehringer Ingelheim
Bold Capital Partners
Bpifrance
Brace Pharma Capital
Brain Canada
Breakout Labs
BridgeBio Pharma
Brigham and Women's Hospital
Brightspark Ventures
Bristol-Myers Squibb
Broad Institute
btov Partners
Builders VC
Bulba Ventures
Busolantix Investment
BVF Partners
C4X Discovery
Caffeinated Capital
Calibr
California Institute of Biomedical Research
Cambia Health Solutions
Cambridge Cancer Genomics
Cambridge Research Centre
Cancer Genetics
Cantos Ventures
CARB-X
CareDx
CaroCure
Casdin Capital
Catalio Capital Management
Catapult Ventures
Cathay Innovation
Causaly
CB Lux
CECS
Celgene
Cellarity
Celsius Therapeutics
Center for the Advancement of Science in Space
CENTOGENE
Centre for the Development of Industrial Technology (CDTI)
Cerebras
Cerevel Therapeutics
Charcot-Marie-Tooth Association
Charles River Laboratories
ChemAlive
ChemAxon
ChemDiv
ChemPass
ChemSpace
Chiesi Farmaceutici
Children's Tumor Foundation
China Canada Angels Alliance
China International Capital Corporation
China Life Healthcare Fund
China Oncology Focus
Chinese Academy of Medical Sciences
Cigna Ventures
City Hill Ventures
Civilization Ventures
CJ HealthCare
Claremont Creek Ventures
Clarus Ventures
Cleveland Clinic
CLI Ventures
Climate-KIC Accelerator
Cloud Pharmaceuticals
CMT Research Foundation
Collaborations Pharmaceuticals
Collaborative Drug Discovery
Collective Scientific
Colt Ventures
ConcertAI
Conifer Point Pharmaceuticals
Cormorant Asset Management
Cosine
Cota Capital
CPP Investments
CQDM - Consortium de recherche biopharmaceutique
Creative Destruction Lab
Cresset
CrystalGenomics
CTI Life Sciences Fund
Cultivian Sandbox Ventures
CVC
CVS Health
Cyclica
CytoReason
Daewoong Pharmaceutical
Danhua Venture Capital
Dante Labs
Data4cure
Dataspora
Datavant
DCVC
DEARGEN
Deep Genomics
Deep Knowledge Ventures
DeepCure
DeepMatter
DeepTrait
Deerfield Management
Delin Ventures
Denali Therapeutics
Denovicon Therapeutics
Denovium
Department of Health and Social Care
DEXSTR
Diamond Light Source
DNAnexus
DNDi
Dolby Family Ventures
Dow AgroSciences
Drive Capital
Droia Oncology Ventures
DSC Investment
Dualogics
Dynamk Capital
Dyno Therapeutics
Echo Health Ventures
EcoR1 Capital
EDBI
EIC Accelerator
Eight Roads
Elad Gil
Elaia
Elevian
Eli Lilly
Elsevier
Elucidata
Embark Ventures
Empire State Development
Empirico
Enamine
Endogena Therapeutics
Endure Capital
Engine Biosciences
Enterprise Ireland
Envisagenics
Epic Capital Management
Epic Ventures
Erasca
e-therapeutics
Euretos
European Investment Bank
European Union
Eurostars
Evaxion Biotech
Evotec
Ewha Womans University
Excelra
Executive Agency for Small and Medium-sized Enterprises (EASME)
Exscientia
Felicis Ventures
Fidelity Asia Fund
Fidelity Biosciences
Fifty Years
Financiere Boscary
FinLab
First Round Capital
First Star Ventures
Flagship Pioneering
Flybridge Capital Partners
FMC
Foresite Capital
Forma Therapeutics
Formic Ventures
Foundation for Angelman Syndrome Therapeutics (FAST)
Founders Factory
Founders Fund
Fountain Therapeutics
Fox Chase Cancer Center
F-Prime Capital
FREES FUND
Frontier Medicines
FundersClub
Future Ventures
G3 Therapeutics
Galapagos
Gatehouse Bio
GC Pharma
Geisinger
Genedata
Genentech
General Atlantic
General Catalyst
Genesen
Genesis Therapeutics
Genialis
Genmab
Genomatica
Genome Biologics
Genome Institute of Singapore
Genomenon
Genomics England
Genuity Science
Gero
Gi Global Health Fund
Gilead Sciences
GlaxoSmithKline
Global Brain
Global Founders Capital
GM&C Life Sciences Fund
GNS Healthcare
Golden Ventures
Google
Google Ventures
Gopher Asset Management
Gordian Biotechnology
Government of Canada
Government of Switzerland
GP Healthcare Capital
GPG Ventures
Grand Challenges Canada
Green Park & Golf Ventures
GreenSky Capital
Gritstone Oncology
GT Healthcare Capital Partners
Gustave Roussy
Hafnium Labs
Hanhai Studio
Harbour Antibodies
Harbour BioMed
Harris & Harris Group
HCS
Health Wildcatters
HealthInc
Healx
Heritage Provider Network
Hewlett Packard Enterprise (HPE)
Hibiskus Biopharma
Hike Ventures
Hinge Therapeutics
Hiventures Investment Fund
HOF Capital
HotSpot Therapeutics
Huadong Medicine
Human Capital
Hyperplane Venture Capital
IA Ventures
IBM
Ichor Biologics
IDG Capital
IIT Kharagpur
Iktos
IMM Investment
Immunocure Discovery Solutions
InfoChem
InnoPharmaScreen
Innophore
Innoplexus
Innospark Ventures
Innova31
Innovate NY Fund
Innovate UK
Innovation Endeavors
Innovation Fund Denmark
Innovative Medicines Initiative (IMI)
Inovia Capital
inSili.com
Insiliance
Insilico Medicine
Insitro
Institut Carnot CALYM
Institut Gustave Roussy
Institut Pasteur Korea
Institute of Cancer Research, London
Institute of Materia Medica
Intel
Intel Capital
Intellegens
IntelliCyt
Intermountain Ventures
Interprotein
Intuition Systems
InveniAI
InVivo AI
Invus
Ionis
IP Group
IPF Partners
IQVIA
Ireland Strategic Investment Fund
I-Stem
IT-Translation
Janssen Pharmaceutica
Jiangsu Chia Tai Fenghai Pharmaceutical
Jiangsu Hansoh Pharmaceutical Group
JLABS
Johns Hopkins School of Medicine
Johns Hopkins University
Johnson & Johnson
Johnson & Johnson Innovation - JJDC
Juvena Therapeutics
Juvenescence
JW Pharmaceutical
K Cube Ventures
K9 Ventures
KB Securities
Kebotix
Keio University
KemPharm
Khosla Ventures
Kindred Capital
Kinetic Discovery
King Star Capital
King's College London
Korea Atomic Energy Research Institute (KAERI)
Korea Development Bank
Korea Fixed-Income Investment Advisory
Korea Investment Partners
Korea Research Institute of Chemical Technology (KRICT)
Ksilink
KTB Network
La Financiere Gaspard
Labcyte
LabGenius
LabKey
Lansdowne Partners
Lantern Pharma
LanzaTech
Laurion Capital Management
Lawrence Livermore National Laboratory
Laxai Life Sciences
LB Investment
Leaps by Bayer
LEO Pharma
Lhasa
LifeForce Capital
LifeSci Venture Partners
Lightspeed Venture Partners
Lilly Asia Ventures
Linguamatics
LMU University Hospital
Lodo Therapeutics
Long Island Emerging technologies Fund (LIETF)
Longevity Fund
Loup Ventures
Lundbeck
Lux Capital
Luxembourg Centre for Systems Biomedicine (LCSB)
M12
MAbSilico
Macroceutics
Magnetic Ventures
Manchester Tech Trust Angels
Mannin Research
Marathon Venture Capital
MaRS Catalyst Fund
Maruho
Massachusetts Life Sciences Center
MassBiologics
Maxygen
MBC BioLabs
McQuibban Lab
MDS Foundation
Medchemica
Medical Prognosis Institute
Medirita
Memorial Sloan Kettering Cancer
Menlo Ventures
Menten AI
Merck
Merck Accelerator
Mercury Fund
Meridian Street Capital
Micar Innovation
Michael J. Fox Foundation
Microsoft
Microsoft Ventures
MidCap Financial
Mila
Mirae Asset Venture Investment
MIT delta v
Mitsui
Molecule
Molecule.one
Moleculomics
Molomics
Monsanto Growth Ventures
MPM Capital
MRL Ventures Fund
Mubadala Capital
Multiple Myeloma Research Foundation
Muscular Dystrophy Association
Muscular Dystrophy UK
myTomorrows
Nan Fung Life Sciences
Nanna Therapeutics
Nashville Biosciences
National Cancer Institute
National Center for Advancing Translational Sciences ( NCATS )
National Center for Research and Development
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Aging (NIA)
National Institutes of Health
National Institutes of Small Business Technology Transfer
National Instrumentation Center for Environmental Management
National Research Council Canada
National Science Foundation
National Science Foundation Small Business Innovation Research (NSF SBIR) program
Nektar Therapeutics
Nest.Bio Ventures
Nestle
Neuropore Therapies
NeuroTheryX
New Protein Capital
New Wave Ventures
New World TMT
New York Medical College
NewDo Venture
Nex Cubed
nference
NJF Capital
Nonacus
Northpond Ventures
Notable Labs
Novartis
Novo Holdings
Novo Nordisk
NPIF - Maven Equity Finance
Numedii
Nuritas
NVIDIA
O2h Ventures
Oak Ridge National Laboratory
Obvious Ventures
OCA Ventures
OccamzRazor
Octopus Ventures
Olaris
Oncologie
OncoStatyx
One Way Ventures
OneThree Biotech
Ono Pharmaceutical
Optibrium
Optum Venture
OrbiMed
OS Fund
OSE Immunotherapeutics
OSEO
Overkill Ventures
OVP Venture Partners
OWKIN
Oxford Drug Design
Panache Ventures
PAREXEL
Parinvest
Parker Institute for Cancer Immunotherapy
Parkinson's UK
Partner Fund Management
Pavilion Capital
PEACCEL
Pear VC
PENDING.AI
Pentech Ventures
Peptone
Peptris Technologies
PercayAI
Perceptive Advisors
Pfizer
Pfizer Venture Investments
Pharmacelera
Pharmavite
PharmCADD
PharmEnable
Pharnext
Pharos iBio
Phenomic AI
PhoreMost
Pi Campus
PIKAS d.o.o.
Plex Research
Plug and Play Ventures
Polaris Partners
Polaris Quantum Biotech
Polyclone Bioservices
Porton
PostEra
PrecisionLife
Predictive Oncology
Prefix Capital
Presight Capital
Primary Venture Partners
Prime Movers Lab
Primordial Genetics
Prism Pharma
Promega
Propagator Ventures
ProteinQure
ProteiQ Biosciences
QIAGEN
Qiming Venture Partners
Quantitative Medicine
Qulab
RA Capital Management
Radical Ventures
Rahko
Ramen Ventures
RaQualia Pharma
Real Ventures
RealHealthData
Recursion Pharmaceuticals
Redalpine
Redbiotec
Redmile Group
Redpoint Ventures
Refactor Capital
Regeneron Pharmaceuticals
Regional Cancer Centre (RCC)
Relation Therapeutics
Relay Therapeutics
Remedium AI
RenalytixAI
Reneo Capital
Renren
ReproCell
Repurpose.AI
Research Triangle Park
Resonant Therapeutics
Reverie Labs
ReviveMed
Rigetti Computing
Rising Tide
Rivas Capital
Roche
Romulus Capital
Rough Draft Ventures
RT Partners
Samsara BioCapital
Sanabil Investments
Sanofi
Sanofi
Santen Pharmaceutical
Saphetor
Sapio Sciences
Sapir Venture Partners
Sarepta Therapeutics
SARomics Biostructures
Saverna Therapeutics
Schrodinger
SciFi VC
Scripps Research
Sea Lane Ventures
Searchbolt
Selvita
Sema4
SEngine Precision Medicine
Seoul National University
Sequoia Capital
Sequoia China
Seraph Group
Serra Ventures
Servier
Siemens
SIG
Sinequa
Sinopia Biosciences
Sinovation Ventures
Sirenas
SK Biopharmaceuticals
SK Holdings
Smilegate Investment
Sofinnova Partners
SoftBank Ventures
SoftTech VC
Solasta Ventures
SolveBio
SOM Biotech
Soma Capital
SOSV
SparkBeyond
Spektron Systems
Spring Discovery
Square 1 Bank
SR One
SRI International
Stage Venture Partners
Standigm
Stanford University
StarFinder
Startupbootcamp
StartX Fund
Stemmore
StemoniX
Stonehaven
Structura Biotechnology
Sunfish Partners
Sunwest Bank
Susa Ventures
Sustainable Conversion Ventures
Sutter Health
SV Angel
Synsight
Syntekabio
Synthelis
Systems Oncology
Taisho Pharmaceutical
Takeda Development Center Americas
Takeda Pharmaceutical
Tanabe Research Laboratories
Tanarra
TARA Biosystems
Tasly Pharmaceutical
Tavistock Group
TB Alliance
Team Builder Ventures
Techammer
TechU
Tekla Capital Management
Temasek Holdings
TenOneTen Ventures
Terra Magnum Capital Partners
TeselaGen
Teva Pharmaceuticals
TF Bioinformatics
The Buck Institute and
The Column Group
The Cure Parkinson's Trust (CPT)
The Edge Software Consultancy
The Longevity Fund
The Partnership Fund for New York City
The Pritzker Organization
The Yozma Group Korea
THERAMetrics
Third Kind Venture Capital
Third Rock Ventures
Three Lakes Partners
Threshold Ventures
Tillotts Pharma
Timewise Investment
Top Technology Ventures
Topspin Fund
Toyohashi University of Technology
TPG Biotech
TPG Capital
Transcriptic
Transilico
Translational Medicine Accelerator
Trinitas Capital
True Ventures
Truffle Capital
TSVC
Turbine.AI
Twin Ventures
Two Sigma Ventures
twoXAR Pharmaceuticals
U.S. Securities and Exchange Commission (SEC)
UC Riverside
UK Biobank
Uncork Capital
Uni-innovate group
Universal Materials Incubator
University College London
University Health Network
University Hospital Institute Mediterranee Infection
University of California
University of Chicago
University of Connecticut
University of Groningen
University of Kentucky
University of Leeds
University of Manitoba
University of Miami
University of Michigan College of Pharmacy
University of Michigan Life Sciences
University of Minnesota
University of Nottingham
University of Oxford
University of Pittsburgh
University of Toronto
University of Wisconsin-Milwaukee Research Foundation
University of North Carolina
Unnatural Products
UPPthera
Upsher-Smith Laboratories
VantAI
Verge Genomics
VeriSIM
Versant Ventures
Viking Global Investors
Village Global
Vingyani
Vir Biotechnology
VisVires New Protein
Vium
Vlaams Instituut voor Biotechnologie (VIB)
VYASA Analytics
Watson Fund
Wave
Wheatsheaf Group
WI Harper
Wild Basin Investments
Wiley
Wisecube
Woodford Investment Management
WorldQuant Ventures
WRF Capital
WuXi AppTec
WuXi Biologics
Wuxi Biortus Biosciences
WuXi Venture Capital
X-37
X-Chem
XtalPi
Y Combinator
Yael Capital
Yale School of Medicine
YITU Technology
Yonsei University College of Medicine
Yuhan
YunFeng Capital
Zastra
ZebiAI
ZhenFund

For more information about this report visit https://www.researchandmarkets.com/r/j28wjg

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets